argenx SE
argenx SE, a commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
Mentions
2 mentions · latest on 19 Jun 2026
| Value Hive PodcastPodcast | Peter Mantas: The Biotech Bubble Whisperer | - | 19 Jun 2026 |
| The Business BrewPodcast | Sonu Chawla - Managing Mid Cap Exposure - $TSCM | - | 26 Mar 2026 |